The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ARRAY BIOPHARMA COM 04269X105 2,884 400,000 SH   SOLE   400,000 0 0
ASSEMBLY BIOSCIENCES COM 045396108 30,317 1,574,107 SH   SOLE   1,574,107 0 0
ATARA BIOTHERAPEUTICS COM 046513107 56,094 1,063,189 SH   SOLE   1,063,189 0 0
ATYR PHARMA COM 002120103 15,499 836,860 SH   SOLE   836,860 0 0
BIOTIE THERAPIES OYJ SPONSORED ADR SPONSORED ADR 09074D103 1,997 100,000 SH   SOLE   100,000 0 0
CALITHERA BIOSCIENCES COM 13089P101 2,967 415,480 SH   SOLE   415,480 0 0
CELLADON COM 15117E107 3,582 2,843,170 SH   SOLE   2,843,170 0 0
COLLEGIUM PHARMACEUTICAL COM 19459J104 8,298 465,118 SH   SOLE   465,118 0 0
EPIZYME COM 29428V104 40,459 1,685,800 SH   SOLE   1,685,800 0 0
FIBROGEN COM 31572Q808 28,327 1,205,391 SH   SOLE   1,205,391 0 0
FLEX PHARMA COM 33938A105 15,629 908,691 SH   SOLE   908,691 0 0
FORWARD PHARMA A/S SPONSORED ADR SPONSORED ADR 34986J105 6,049 158,985 SH   SOLE   158,985 0 0
GENVEC COM 37246C307 4,052 1,986,413 SH   SOLE   1,986,413 0 0
KINDRED BIOSCIENCES COM 494577109 8,828 1,294,431 SH   SOLE   1,294,431 0 0
KITE PHARMA COM 49803L109 17,157 281,400 SH   SOLE   281,400 0 0
QLT COM 746927102 1,652 400,000 SH   SOLE   400,000 0 0
RETROPHIN COM 761299106 11,326 341,650 SH   SOLE   341,650 0 0
SERES THERAPEUTICS COM 81750R102 1,660 40,000 SH   SOLE   40,000 0 0
TARGACEPT COM 87611R306 1,729 619,699 SH   SOLE   619,699 0 0
XENON PHARMACEUTICALS COM 98420N105 842 73,000 SH   SOLE   73,000 0 0
ARRAY BIOPHARMA SR CONV NT 3.000% Due 06/01/2020 NOTE 04269XAA3 24,240 19,200,000 PRN   SOLE   19,200,000 0 0
ARRAY BIOPHARMA COM 04269X905 4,146 5,750 SH Call SOLE   5,750 0 0
ARRAY BIOPHARMA COM 04269X905 3,785 5,250 SH Call SOLE   5,250 0 0
EPIZYME COM 29428V904 360 150 SH Call SOLE   150 0 0
OVASCIENCE COM 69014Q901 868 300 SH Call SOLE   300 0 0
OVASCIENCE COM 69014Q901 5,786 2,000 SH Call SOLE   2,000 0 0
REGULUS THERAPEUTICS COM 75915K901 1,403 1,280 SH Call SOLE   1,280 0 0